Pricing & Access Lead, Endocrinology
Alexion Pharmaceuticals, Inc.Barcelona, Catalonia, Spain
Posted April 8, 2026
Full Time
About the Company
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Job Description
Join a highly valued, strategic team to lead the development and execution of global value, access, and price strategies for Eneboparatide & hypoparathyroidism pipeline to support patient access to medicines. This is a strategic role requiring an ability to shape a global value, access, and pricing strategy across the diversity of our US/Japan/EU key rare diseases markets.
Requirements
- Value
- Lead and drive across function development of a clear differentiated Eneboparatide asset value proposition
- Keep up to date with scientific developments
- Influence Clinical Development Programs of Endocrinology assets portfolio
- Provide support to GMMA commercial team
- Access
- Lead a cross functional team to drive hypoparathyroidism Global market access and pricing strategies
- Create and roll out of strategic value, access, and pricing communication tools and materials
- Represent GVAP perspective and strategy across various cross-functional teams
- Pricing
- Develop Eneboparatide launch & hypoparathyroidism therapies pricing strategy
- Conduct payer and value assessments to identify key market specific P&R drivers and barriers
- Targeting the top 8 rare diseases markets, Lead and co-create market level P&R strategies
Benefits
- Competitive salary
- Benefits package
- Opportunities for professional growth and development
